1.

Record Nr.

UNINA9910464804303321

Titolo

Future uses of the Department of Defense Joint Pathology Center Biorepository / / Committee on the Review of the Appropriate Use of AFIP's Tissue Repository Following Its Transfer to the Joint Pathology Center, Board on the Health of Select Populations, Institute of Medicine of the National Academies

Pubbl/distr/stampa

Washington, District of Columbia : , : National Academies Press, , [2012]

©2012

ISBN

0-309-26066-3

Descrizione fisica

1 online resource (199 p.)

Disciplina

570.7

Soggetti

Biobanks - Standards - United States

Biological specimens - Handling - Standards - United States

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

Introduction and background -- Determinates of the research value of biospecimens -- Ethical, legal, and regulatory considerations -- Findings, conclusions, and recommendations.

Appendices: Public meeting agendas -- Contributor's consultation request form Joint Pathology Center -- DoD instruction 3126.02, Protection of human subjects and adherence to ethical standards in DoD-supported research.

Sommario/riassunto

"Founded during the Civil War as the Army Medical Museum, the Armed Forces Institute of Pathology (AFIP) amassed the world's largest collection of human pathologic specimens and was considered a premier consultation, education, and research facility by the end of the 20th century. Samples from the AFIP were instrumental in helping to solve public health mysteries, such as the sequence of the genome of the 1918 influenza virus that killed more than 40 million people worldwide. In 2005, the federal Base Realignment and Closure Commission recommended that the AFIP be closed, and its biorepository was transferred to the newly created Joint Pathology



Center. During the transition, the Department of Defense asked the IOM to provide advice on operating the biorepository, managing its collection, and determining appropriate future use of specimens for consultation, education, and research. Future Uses of the Department of Defense Joint Pathology Center Biorepository, the IOM proposes a series of protocols, standards, safeguards, and guidelines that could help to ensure that this national treasure continues to be available to researchers in the years to come, while protecting the privacy of the people who provided the materials and maintaining the security of their personal information."--Publisher's description.

2.

Record Nr.

UNINA9910460115403321

Autore

Bohme Susanna Rankin <1973->

Titolo

Toxic injustice : a transnational history of exposure and struggle / / Susanna Rankin Bohme

Pubbl/distr/stampa

Oakland, California : , : University of California Press, , 2014

©2014

ISBN

0-520-27899-2

0-520-95981-7

Descrizione fisica

1 online resource (357 p.)

Disciplina

363.738/4

Soggetti

Dibromochloropropane - Toxicology

Dibromochloropropane - Health aspects - Law and legislation

Agricultural laborers - Health and hygiene

Environmental justice

Fruit trade - Health aspects - Law and legislation

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Front matter -- Contents -- List of Illustrations -- Acknowledgments -- Introduction -- 1. Roots of Optimism and Anxiety -- 2. DBCP on the Farm -- 3. Unequal Exposures -- 4. An Inconvenient Forum? -- 5. Making a Movement -- 6. National Law, Transnational Justice? --



Conclusion -- Notes -- Selected Bibliography -- Index

Sommario/riassunto

The pesticide dibromochloropropane, known as DBCP, was developed by the chemical companies Dow and Shell in the 1950's to target wormlike, soil-dwelling creatures called nematodes. Despite signs that the chemical was dangerous, it was widely used in U.S. agriculture and on Chiquita and Dole banana plantations in Central America. In the late 1970's, DBCP was linked to male sterility, but an uneven regulatory process left many workers-especially on Dole's banana farms-exposed for years after health risks were known. Susanna Rankin Bohme tells an intriguing, multilayered history that spans fifty years, highlighting the transnational reach of corporations and social justice movements. Toxic Injustice links health inequalities and worker struggles as it charts how people excluded from workplace and legal protections have found ways to challenge power structures and seek justice from states and transnational corporations alike.